Abstract

 Insulinoma is primarily a pancreatic neuroendocrine tumour, known to be rare and benign, in 90% of cases, while 10% cases are developed in Multiple Endocrine Neoplasia patients. The age of onset is 50 years, except for the malignant forms related to the MEN syndrome cases, where it appears between 20 and 40 years of age. The clinical findings and blood chemistry parameters coupled with the imaging techniques (Echo-endoscopy, CT, MRI) make it possible to locate the tumour in 80% of cases. The treatment of choice is essentially surgical, such as enucleation or removal of part of the pancreas.

Keywords: Pancreas; Hypoglycemia; Endocrine Tumour; Neuroendocrine Tumour

References

1. Service FJ., et al. “Functioning insulinoma: incidence, recurrence, and long term survival of patients: a 60-year study”. Mayo Clinic Proceedings 7 (1991): 711-719.
2. Liu Y., et al. “The value of multidetector-row CT in the preoperative detection of pancreatic insulinomas”. Radiology Medicine8 (2009): 1232-1238.
3. Fidler JL., et al. “Preoperative detection of pancreatic insulinomas on multiphasic helical CT”. American Journal of Roentgenology 3 (2003): 775-780.
4. Rich TA and Perrier ND. “Multiple endocrine neoplasia syndromes”. Surgical Clinics of North America 4 (2008): 863-895.
5. Bégu-Le Corroller A., et al. “Aggressive multimodal therapy of sporadic malignant insulinoma can improve survival: a retrospective 35-year study of 12 patients”. Diabetes Metabolism4 (2008): 343-348.
6. Horton K., et al. “Multi-detector row CT of pancreatic islet cell tumors”. Radio Graphics 2 (2006): 453-464.
7. Graves TD., et al. “Misdiagnosis of seizures: insulinoma presenting as adult-onset seizure disorder”. Journal of Neurology, Neurosurgery, and Psychiatry 8 (2004): 1091-1092.
8. Elisabeth AM., et al. “Giant insulinoma: case report and review of the literature”. The Journal of Clinical Endocrinology and Metabolism 1 (2004): 575-580.
9. Sebbag-Sfeza D., et al. “Insulinome pédiculé au bord antérieur de la tête du pancréas: une localisation exceptionnelle à connaître”. Journal de Radiologie Diagnostique et Interventionnelle 3 (2013): 335-338.
10. Proye C and Lokey JS. “Current concepts in functioning endocrine tumors of the pancreas”. World Journal of Surgery 12 (2004): 1231-1238.
11. Peix J-L and Proye C. “Stratégie et technique dans le traitement chirurgical des tumeurs endocrines duodénopancréatiques”. Techniques chirurgicales Appareil digestif1 (2006): 883-891.
12. De Herder WW., et al. “Well differentiated pancreatic tumor/carcinoma: insulinoma”. Neuroendocrinology3 (2006): 183-188.
13. Kulke MH., et al. “Glycemic control in patients with insulinoma treated with everolimus”. The New England Journal of Medicine 2 (2009): 195-197.
14. Jensen RT., et al. “ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes”. Neuroendocrinology 2 (2012): 98-119.
15. Ong GS., et al. “Therapies for the medical management of persistent hypoglycaemia in two cases of inoperable malignant insulinoma”. European Journal of Endocrinology 5 (2010): 1001-1008.
16. Falconi M., et al. “ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors”. Neuroendocrinology2 (2012): 120-134.
17. Hill JS., et al. “Pancreatic neuroendocrine tumors: the impact of surgical resection on survival”. Cancer 4 (2009): 741-745.
18. Ketari-Jamoussi S., et al. “Un insulinome géant: à propos d'un cas”. Annales d'Endocrinologie1 (2009): 71-75.
19. Baudin E., et al. “Recommendations pour la prise en charge de l'insulinome malin”. La Presse Médicale 6 (2014): 645-659.

Citation

Citation: Ismail Abdillahi Iltireh., et al. “Pancreatic Insulinoma - The Once in a Blue Moon Oncological Episode". Acta Scientific Clinical Case Reports 1.8 (2020): 03-07.

Copyright

Copyright: © 2020 Ismail Abdillahi Iltireh., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.